Cargando…

Establishing Classifiers With Clinical Laboratory Indicators to Distinguish COVID-19 From Community-Acquired Pneumonia: Retrospective Cohort Study

BACKGROUND: The initial symptoms of patients with COVID-19 are very much like those of patients with community-acquired pneumonia (CAP); it is difficult to distinguish COVID-19 from CAP with clinical symptoms and imaging examination. OBJECTIVE: The objective of our study was to construct an effectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Wanfa, Ke, Pei-Feng, Li, Zhen-Zhen, Zhuang, Qi-Zhen, Huang, Wei, Wang, Yi, Xiong, Yujuan, Huang, Xian-Zhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901596/
https://www.ncbi.nlm.nih.gov/pubmed/33534722
http://dx.doi.org/10.2196/23390
_version_ 1783654400718274560
author Dai, Wanfa
Ke, Pei-Feng
Li, Zhen-Zhen
Zhuang, Qi-Zhen
Huang, Wei
Wang, Yi
Xiong, Yujuan
Huang, Xian-Zhang
author_facet Dai, Wanfa
Ke, Pei-Feng
Li, Zhen-Zhen
Zhuang, Qi-Zhen
Huang, Wei
Wang, Yi
Xiong, Yujuan
Huang, Xian-Zhang
author_sort Dai, Wanfa
collection PubMed
description BACKGROUND: The initial symptoms of patients with COVID-19 are very much like those of patients with community-acquired pneumonia (CAP); it is difficult to distinguish COVID-19 from CAP with clinical symptoms and imaging examination. OBJECTIVE: The objective of our study was to construct an effective model for the early identification of COVID-19 that would also distinguish it from CAP. METHODS: The clinical laboratory indicators (CLIs) of 61 COVID-19 patients and 60 CAP patients were analyzed retrospectively. Random combinations of various CLIs (ie, CLI combinations) were utilized to establish COVID-19 versus CAP classifiers with machine learning algorithms, including random forest classifier (RFC), logistic regression classifier, and gradient boosting classifier (GBC). The performance of the classifiers was assessed by calculating the area under the receiver operating characteristic curve (AUROC) and recall rate in COVID-19 prediction using the test data set. RESULTS: The classifiers that were constructed with three algorithms from 43 CLI combinations showed high performance (recall rate >0.9 and AUROC >0.85) in COVID-19 prediction for the test data set. Among the high-performance classifiers, several CLIs showed a high usage rate; these included procalcitonin (PCT), mean corpuscular hemoglobin concentration (MCHC), uric acid, albumin, albumin to globulin ratio (AGR), neutrophil count, red blood cell (RBC) count, monocyte count, basophil count, and white blood cell (WBC) count. They also had high feature importance except for basophil count. The feature combination (FC) of PCT, AGR, uric acid, WBC count, neutrophil count, basophil count, RBC count, and MCHC was the representative one among the nine FCs used to construct the classifiers with an AUROC equal to 1.0 when using the RFC or GBC algorithms. Replacing any CLI in these FCs would lead to a significant reduction in the performance of the classifiers that were built with them. CONCLUSIONS: The classifiers constructed with only a few specific CLIs could efficiently distinguish COVID-19 from CAP, which could help clinicians perform early isolation and centralized management of COVID-19 patients.
format Online
Article
Text
id pubmed-7901596
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-79015962021-03-02 Establishing Classifiers With Clinical Laboratory Indicators to Distinguish COVID-19 From Community-Acquired Pneumonia: Retrospective Cohort Study Dai, Wanfa Ke, Pei-Feng Li, Zhen-Zhen Zhuang, Qi-Zhen Huang, Wei Wang, Yi Xiong, Yujuan Huang, Xian-Zhang J Med Internet Res Original Paper BACKGROUND: The initial symptoms of patients with COVID-19 are very much like those of patients with community-acquired pneumonia (CAP); it is difficult to distinguish COVID-19 from CAP with clinical symptoms and imaging examination. OBJECTIVE: The objective of our study was to construct an effective model for the early identification of COVID-19 that would also distinguish it from CAP. METHODS: The clinical laboratory indicators (CLIs) of 61 COVID-19 patients and 60 CAP patients were analyzed retrospectively. Random combinations of various CLIs (ie, CLI combinations) were utilized to establish COVID-19 versus CAP classifiers with machine learning algorithms, including random forest classifier (RFC), logistic regression classifier, and gradient boosting classifier (GBC). The performance of the classifiers was assessed by calculating the area under the receiver operating characteristic curve (AUROC) and recall rate in COVID-19 prediction using the test data set. RESULTS: The classifiers that were constructed with three algorithms from 43 CLI combinations showed high performance (recall rate >0.9 and AUROC >0.85) in COVID-19 prediction for the test data set. Among the high-performance classifiers, several CLIs showed a high usage rate; these included procalcitonin (PCT), mean corpuscular hemoglobin concentration (MCHC), uric acid, albumin, albumin to globulin ratio (AGR), neutrophil count, red blood cell (RBC) count, monocyte count, basophil count, and white blood cell (WBC) count. They also had high feature importance except for basophil count. The feature combination (FC) of PCT, AGR, uric acid, WBC count, neutrophil count, basophil count, RBC count, and MCHC was the representative one among the nine FCs used to construct the classifiers with an AUROC equal to 1.0 when using the RFC or GBC algorithms. Replacing any CLI in these FCs would lead to a significant reduction in the performance of the classifiers that were built with them. CONCLUSIONS: The classifiers constructed with only a few specific CLIs could efficiently distinguish COVID-19 from CAP, which could help clinicians perform early isolation and centralized management of COVID-19 patients. JMIR Publications 2021-02-22 /pmc/articles/PMC7901596/ /pubmed/33534722 http://dx.doi.org/10.2196/23390 Text en ©Wanfa Dai, Pei-Feng Ke, Zhen-Zhen Li, Qi-Zhen Zhuang, Wei Huang, Yi Wang, Yujuan Xiong, Xian-Zhang Huang. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 22.02.2021. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Dai, Wanfa
Ke, Pei-Feng
Li, Zhen-Zhen
Zhuang, Qi-Zhen
Huang, Wei
Wang, Yi
Xiong, Yujuan
Huang, Xian-Zhang
Establishing Classifiers With Clinical Laboratory Indicators to Distinguish COVID-19 From Community-Acquired Pneumonia: Retrospective Cohort Study
title Establishing Classifiers With Clinical Laboratory Indicators to Distinguish COVID-19 From Community-Acquired Pneumonia: Retrospective Cohort Study
title_full Establishing Classifiers With Clinical Laboratory Indicators to Distinguish COVID-19 From Community-Acquired Pneumonia: Retrospective Cohort Study
title_fullStr Establishing Classifiers With Clinical Laboratory Indicators to Distinguish COVID-19 From Community-Acquired Pneumonia: Retrospective Cohort Study
title_full_unstemmed Establishing Classifiers With Clinical Laboratory Indicators to Distinguish COVID-19 From Community-Acquired Pneumonia: Retrospective Cohort Study
title_short Establishing Classifiers With Clinical Laboratory Indicators to Distinguish COVID-19 From Community-Acquired Pneumonia: Retrospective Cohort Study
title_sort establishing classifiers with clinical laboratory indicators to distinguish covid-19 from community-acquired pneumonia: retrospective cohort study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901596/
https://www.ncbi.nlm.nih.gov/pubmed/33534722
http://dx.doi.org/10.2196/23390
work_keys_str_mv AT daiwanfa establishingclassifierswithclinicallaboratoryindicatorstodistinguishcovid19fromcommunityacquiredpneumoniaretrospectivecohortstudy
AT kepeifeng establishingclassifierswithclinicallaboratoryindicatorstodistinguishcovid19fromcommunityacquiredpneumoniaretrospectivecohortstudy
AT lizhenzhen establishingclassifierswithclinicallaboratoryindicatorstodistinguishcovid19fromcommunityacquiredpneumoniaretrospectivecohortstudy
AT zhuangqizhen establishingclassifierswithclinicallaboratoryindicatorstodistinguishcovid19fromcommunityacquiredpneumoniaretrospectivecohortstudy
AT huangwei establishingclassifierswithclinicallaboratoryindicatorstodistinguishcovid19fromcommunityacquiredpneumoniaretrospectivecohortstudy
AT wangyi establishingclassifierswithclinicallaboratoryindicatorstodistinguishcovid19fromcommunityacquiredpneumoniaretrospectivecohortstudy
AT xiongyujuan establishingclassifierswithclinicallaboratoryindicatorstodistinguishcovid19fromcommunityacquiredpneumoniaretrospectivecohortstudy
AT huangxianzhang establishingclassifierswithclinicallaboratoryindicatorstodistinguishcovid19fromcommunityacquiredpneumoniaretrospectivecohortstudy